Janssen
Janssen and Partners Discontinue Mosaico HIV Vaccine Trial
The phase 3 Mosaico HIV vaccine clinical trial was discontinued because evidence of efficacy was lacking, according ...
JANUARY 20, 2023

FDA Grants New Indication for Cabenuva for Every-8–Week Dosing
The FDA extended the time between shots of Cabenuva to every two months to treat HIV-1 infection in virologically ...
FEBRUARY 1, 2022

FDA Okays Stelara for UC
The FDA has approved the use of ustekinumab (Stelara, Janssen) for the treatment of moderate to severe ulcerative ...
OCTOBER 21, 2019

Single-Tablet Combo as Effective as Current HIV Treatment
If approved in the U.S., D/C/F/TAF would be the only complete regimen that could deliver the potential adherence ...
OCTOBER 11, 2017

FDA Rejects Sirukumab for RA, Requests More Data
In its complete response letter for sirukumab, the FDA said additional clinical data are needed to evaluate the ...
SEPTEMBER 27, 2017

FDA Issues Warning Regarding Risk for Amputations With Diabetes Drug
The FDA issued a boxed warning for canagliflozin because it can increase the risk for leg and foot amputations.
MAY 23, 2017

2-Drug Combination Effective in Maintaining Viral Suppression in HIV Patients
The requirement of lifelong treatment for HIV infection has highlighted a need to minimize cumulative drug ...
FEBRUARY 17, 2017

FDA Grants New Indication for Imbruvica for Marginal Zone Lymphoma
Prior to this indication, there were no FDA-approved therapies specifically for this disease.
JANUARY 19, 2017

FDA Gives New Indication for Darzalex With 2 Standard Treatments for MM
Daratumumab induces tumor cell death through multiple immune-mediated mechanisms of action, including ...
NOVEMBER 22, 2016

New Noninferiority Data for Biosimilar Infliximab
Biosimilar infliximab is not inferior to the originator product, Remicade in treating rheumatoid arthritis and ...
OCTOBER 20, 2016

Janssen, ViiV Healthcare Collaborate on HIV Regimen Study
A two-drug combination of cabotegravir and rilpivirine is being studied for HIV.
JANUARY 19, 2016
